Bristol Myers Squibb BMY announced that it has obtained a positive opinion from the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency for two of its drugs. The ...

The Marquie Group, Inc. (OTCMKTS: TMGI) is proud to announce a strategic shift in its Simply Whim subsidiary, refocusing the Whim brand on products designed specifically for cancer patients. Following ...

Jörg Mayer, DVM, MS, DABVP, DECZM, DACZM, discusses how bee venom and honey benefits veterinary oncology, in a dvm360 ...

The committee recommended the new formulation in two EGFR-mutated advanced NSCLC settings, for which intravenous Rybrevant is already available.

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

painful chemotherapy-induced peripheral neuropathy. A new meta-analysis of data from 77 studies across 28 countries – including nearly 11,000 patients – is the first study to offer a ...

The committee's recommendation was based on data from the TROPION-Breast01 trial, which also supported the US approval of Datroway in January.

Of 182 patients treated at an orthopedic sports medicine clinic, more than 80% were open to receiving THC and CBD products for pain. More than 60% of patients were familiar with the use of THC and ...